Vanqua Bio

Chicago, IL · Founded 2019 · Privately Held (backing)

Operator of a biopharmaceutical company intended to discover and develop next-generation medicines for neurodegenerative diseases. Vanqua Bio is based in Chicago, IL and was founded in 2019. Its last known valuation is $270 million. It has raised $149 million across 2 recorded rounds; the latest was a $45 million early-stage round in Feb 2024.

Last price · $/share
—
Implied valuation
$270.0M
Total raised
$149.0M
Last round
Early Stage VC
Feb 2024
How much has Vanqua Bio raised?
$149.0Macross 2 recorded rounds · Aug 2021 – Feb 2024

Most recently, Vanqua Bio raised $45.0M in its Early Stage VC (Feb 2024).

Free account
More of Vanqua Bio with a free account
  • ·The complete investor list: 12 names
  • ·Watch Vanqua Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Vanqua Bio round by round

2 rounds
Feb 2024Early Stage VC$45.0MSEC filing▮
12 investors participated
Aug 2021Later Stage VC$85.0MSEC filing▮
11 investors participated

How much has Vanqua Bio raised?

Vanqua Bio has raised $149 million across 2 recorded rounds since 2021. The largest was an $85 million later-stage round in Aug 2021; the most recent was a $45 million early-stage round in Feb 2024.

Vanqua Bio has filed 2 Form Ds with the SEC since 2021, most recently in Jul 2024 ($45 million sold to 12 investors).

Vanqua Bio investors

12 investors are on record for Vanqua Bio, including OrbiMed, Osage University Partners, Casdin Capital and Logos Capital. By type, the record holds 2 venture capital firms, 2 hedge funds and 1 private equity firm. The early-stage round in Feb 2024 drew 12 investors.

For fundraisers
Raising for a company like Vanqua Bio?

12 investors have backed Vanqua Bio.

See all 12 investors →

Frequently asked about Vanqua Bio

How much has Vanqua Bio raised?
Vanqua Bio has raised $149.0M in total across 2 recorded funding rounds.
When was Vanqua Bio's last funding round?
Vanqua Bio's most recent recorded round was Early Stage VC in Feb 2024, raising $45.0M.